Ebos Group Limited (ASX: EBO)
Sector: Health Care
Market cap: A$3.5B (as of 2 Nov 2026)
Diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 27 Feb 2026 | Stuart McLauchlan | Bought 1,500 ordinary shares | Filing ↗ |
| 5 Dec 2025 | Coline McConville | Bought 1,000 ordinary shares | Filing ↗ |
| 27 Nov 2025 | Julie Tay | Bought 1,000 ordinary shares | Filing ↗ |
| 10 Nov 2025 | Matthew Muscio | Bought 3,800 ordinary shares | Filing ↗ |
| 30 Oct 2025 | Tracey Leigh Batten | Bought 2,728 ordinary shares | Filing ↗ |
Latest guidance
| Date | Period | Guidance | Source |
|---|---|---|---|
| 22 Apr 2026 | FY26 | the Group now expects FY26 underlying EBITDA of approximately $610–$620 million, compared with prior guidance of $615–$635 million | Filing ↗ |
Ask about EBO in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has EBO raised money in the last year, and at what discount?
- What was EBO's latest cash position and runway?
Loading EBO…